What Researchers Did
Researchers reviewed existing literature on radiation myelopathy, a rare complication of radiation therapy for extraspinal tumors.
What They Found
They found that radiation myelopathy is a rare but increasing complication of radiation therapy for extraspinal tumors, with a cord dose of 1000 rad potentially being dangerous and risk increasing with higher doses. The incidence depends on radiation technique factors like dose rate and field size, as well as patient variables such as individual radiosensitivity and co-existing conditions like hypertension.
What This Means for Canadian Patients
Canadian patients undergoing radiation therapy for extraspinal tumors should be aware of radiation myelopathy as a rare but serious potential complication. Discussing individual risk factors, including total radiation dose, treatment technique, and pre-existing conditions like hypertension, with their oncology team is important for personalized care.
Canadian Relevance
This study has no direct Canadian connection as it is a literature review from 1976 without specific Canadian data or authors.
Study Limitations
As a literature review from 1976, this study's findings may not reflect current radiation therapy practices and understanding of radiation myelopathy.